Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nimodipine for cognitive impairment after ischemic stroke
NCT01220622Phase 4Unknown
- Start
- Oct 2010
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nimodipine in cognitive impairment. Status: unknown.
02
Drugs
nimodipine
03
Conditions
cognitive impairment
Beyond the preview
Go deeper on NCT01220622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01220622.